Found: 69
Select item for more details and to access through your institution.
PARP Inhibition in Breast Cancer: An Update.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 1
- By:
- Publication type:
- Article
Hong Kong consensus recommendations on the management of pancreatic ductal adenocarcinoma.
- Published in:
- Hong Kong Medical Journal, 2024, v. 30, n. 2, p. 147, doi. 10.12809/hkmj2210476
- By:
- Publication type:
- Article
Risks and impacts of thromboembolism in patients with pancreatic cancer.
- Published in:
- Hong Kong Medical Journal, 2023, v. 29, n. 5, p. 396, doi. 10.12809/hkmj219788
- By:
- Publication type:
- Article
Systemic treatment of pancreatic neuroendocrine tumors.
- Published in:
- Surgical Practice, 2019, v. 23, n. 2, p. 48, doi. 10.1111/1744-1633.12351
- By:
- Publication type:
- Article
Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinoma.
- Published in:
- Liver International, 2012, v. 32, n. 2, p. 271, doi. 10.1111/j.1478-3231.2011.02634.x
- By:
- Publication type:
- Article
Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.64356
- By:
- Publication type:
- Article
Economic analysis of aprepitant-containing regimen to prevent chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Hong Kong.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2014, v. 10, n. 1, p. 80, doi. 10.1111/ajco.12170
- By:
- Publication type:
- Article
Selecting the right patients for testing novel agents in hepatocellular carcinoma: who, when and how?
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2013, v. 9, n. 1, p. 2, doi. 10.1111/ajco.12061
- By:
- Publication type:
- Article
Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: An Asian perspective.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2012, v. 8, n. 2, p. 111, doi. 10.1111/j.1743-7563.2012.01551.x
- By:
- Publication type:
- Article
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 5, p. 1375, doi. 10.1007/s10637-021-01111-8
- By:
- Publication type:
- Article
Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma?
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133213
- By:
- Publication type:
- Article
Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1526, doi. 10.3390/cancers14061526
- By:
- Publication type:
- Article
Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B: A Multinational Study for the Development and External Validation of a New Prognostic Model.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 10, p. 1308, doi. 10.7326/M24-0384
- By:
- Publication type:
- Article
Organ‐specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1961, doi. 10.1111/liv.15935
- By:
- Publication type:
- Article
The combination of ALBI and AFP response: A small step forward in HCC.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 271, doi. 10.1111/liv.15494
- By:
- Publication type:
- Article
Issue Cover.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. i, doi. 10.1111/liv.14277
- By:
- Publication type:
- Article
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2214, doi. 10.1111/liv.14223
- By:
- Publication type:
- Article
Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma.
- Published in:
- Liver International, 2017, v. 37, n. 2, p. 280, doi. 10.1111/liv.13218
- By:
- Publication type:
- Article
Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 2, p. 119, doi. 10.1159/000531458
- By:
- Publication type:
- Article
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 321, doi. 10.1159/000529574
- By:
- Publication type:
- Article
Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 510, doi. 10.1159/000516490
- By:
- Publication type:
- Article
Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 510, doi. 10.1159/000516490
- By:
- Publication type:
- Article
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 2572, doi. 10.1002/cam4.5123
- By:
- Publication type:
- Article
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 4, p. 909, doi. 10.3350/cmh.2023.0114
- By:
- Publication type:
- Article
The prime time for management of hepatocellular carcinoma in Hong Kong.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 345, doi. 10.3350/cmh.2023.0094
- By:
- Publication type:
- Article
Personalized treatment for hepatocellular carcinoma: Current status and future perspectives.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 7, p. 1197, doi. 10.1111/jgh.15889
- By:
- Publication type:
- Article
Endoscopic ultrasound‐guided cyanoacrylate injection to prevent rebleeding in hepatocellular carcinoma patients with variceal hemorrhage.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 12, p. 2192, doi. 10.1111/jgh.15168
- By:
- Publication type:
- Article
Genetic variation in ABCB5 associates with risk of hepatocellular carcinoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 18, p. 10705, doi. 10.1111/jcmm.15691
- By:
- Publication type:
- Article
Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients.
- Published in:
- Clinical Chemistry, 2022, v. 68, n. 9, p. 1151, doi. 10.1093/clinchem/hvac086
- By:
- Publication type:
- Article
Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma.
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 11, p. 1492, doi. 10.1093/clinchem/hvab116
- By:
- Publication type:
- Article
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing.
- Published in:
- Clinical Chemistry, 2013, v. 59, n. 1, p. 211, doi. 10.1373/clinchem.2012.196014
- By:
- Publication type:
- Article
Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index for Hepatocellular Carcinoma.
- Published in:
- Disease Markers, 2015, v. 2015, p. 1, doi. 10.1155/2015/564057
- By:
- Publication type:
- Article
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.
- Published in:
- Histopathology, 2016, v. 69, n. 6, p. 971, doi. 10.1111/his.13029
- By:
- Publication type:
- Article
Expression of stemness markers ( CD133 and Ep CAM) in prognostication of hepatocellular carcinoma.
- Published in:
- Histopathology, 2014, v. 64, n. 7, p. 935, doi. 10.1111/his.12342
- By:
- Publication type:
- Article
Reply to 'Comment on 'Circulating Neutrophils in patients with hepatocellular carcinoma".
- Published in:
- 2018
- By:
- Publication type:
- Letter
Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The association of liver function and quality of life of patients with liver cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 9, p. 1, doi. 10.1038/s41419-018-0926-x
- By:
- Publication type:
- Article
Contaminated and misidentified cell lines commonly use in cancer research.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 6, p. 573, doi. 10.1002/mc.23189
- By:
- Publication type:
- Article
Analysis by Treatment Period and Liver Function in EMERALD-1: Phase 3 Study of Durvalumab (D) With/Without Bevacizumab (B) With Transarterial Chemoembolization (TACE) in Unresectable Hepatocellular Carcinoma (uHCC) Eligible for Embolization.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2024, v. 15, n. 10, p. 327
- By:
- Publication type:
- Article
Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 2719, doi. 10.2147/CMAR.S178482
- By:
- Publication type:
- Article
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 16, p. 2720, doi. 10.1002/cncr.29413
- By:
- Publication type:
- Article
Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alpha.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Intermittent versus continuous erlotinib with concomitant modified 'XELOX' (q3W) in first-line treatment of metastatic colorectal cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 23, p. 4145, doi. 10.1002/cncr.28327
- By:
- Publication type:
- Article
A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 16, p. 3984, doi. 10.1002/cncr.26726
- By:
- Publication type:
- Article